Synonyms: AMG-634 | CC-11050
Compound class:
Synthetic organic
Comment: Dovramilast is a phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory properties. It is in clinical development as an adjunctive host-directed therapy, to be used in the treatment of leprosy (Hansen's disease) and in combination with conventional antibacterial regimens as a strategy for shortening the duration of treatment for tuberculosis (TB).
|
|
Bioactivity Comments |
Dovramilast demonstrates efficacy in preclinical models of Mycobacterium tuberculosis infection, when used as an adjunctive host-directed therapy in combination with first-line TB drugs [1-2]. |